These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 21950193)
1. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis]. Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193 [TBL] [Abstract][Full Text] [Related]
2. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp]. Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482 [TBL] [Abstract][Full Text] [Related]
3. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242 [TBL] [Abstract][Full Text] [Related]
4. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis. Hernández-Chinea C Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625 [TBL] [Abstract][Full Text] [Related]
5. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana. Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana. Dissanayake S; Shahin A; Ameen AM Mol Immunol; 2005 Aug; 42(12):1495-502. PubMed ID: 15950742 [TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection. Campbell SA; Alawa J; Doro B; Henriquez FL; Roberts CW; Nok A; Alawa CB; Alsaadi M; Mullen AB; Carter KC Vaccine; 2012 Feb; 30(7):1357-63. PubMed ID: 22210224 [TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6). Malchiodi EL; Chiaramonte MG; Taranto NJ; Zwirner NW; Margni RA Clin Exp Immunol; 1994 Sep; 97(3):417-23. PubMed ID: 8082296 [TBL] [Abstract][Full Text] [Related]
9. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients. Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan. Halliday A; Bates PA; Chance ML; Taylor MJ Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391 [TBL] [Abstract][Full Text] [Related]
13. CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model. Ali SA; Rezvan H; McArdle SE; Khodadadi A; Asteal FA; Rees RC Parasite Immunol; 2009 Jul; 31(7):373-83. PubMed ID: 19527453 [TBL] [Abstract][Full Text] [Related]
14. Anti-Leishmania IgA in urine samples from dogs with clinical leishmaniasis. Todolí F; Solano-Gallego L; Ojeda A; Quintana J; Lloret A; Roura X; Alberola J; Rodríguez-Cortés A Vet Parasitol; 2009 Jan; 159(1):17-23. PubMed ID: 19019547 [TBL] [Abstract][Full Text] [Related]
15. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages. Reis MG; Roters SB; Barral-Netto M Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370 [TBL] [Abstract][Full Text] [Related]
16. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis]. Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166 [TBL] [Abstract][Full Text] [Related]
17. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants. Pan AA; McMahon-Pratt D J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920 [TBL] [Abstract][Full Text] [Related]
19. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages. Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349 [TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Trypanosoma cruzi and Leishmania mexicana in free-ranging howler monkeys in southeastern Mexico. Rovirosa-Hernández Mde J; Cortes-Ortíz L; García-Orduña F; Guzmán-Gómez D; López-Monteon A; Caba M; Ramos-Ligonio A Am J Primatol; 2013 Feb; 75(2):161-9. PubMed ID: 23165742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]